Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

57.26 -0.75 (-1.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PTC Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Earnings Preview: PTC Therapeutics
 
Via Benzinga
Why PTC Therapeutics Soared 15% Higher Today
The company scored a $1 billion upfront payment for expanding a commercial partnership. 
Via The Motley Fool
Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded down 0.43% to 33,520.17 while the NASDAQ fell 0.75% to 13,214.04. The... 
Via Benzinga
Topics Stocks
Expert Ratings for PTC Therapeutics
 
Via Benzinga
Where PTC Therapeutics Stands With Analysts
 
Via Benzinga
Raymond James Maintains Outperform Rating for PTC Therapeutics: Here's What You Need To Know
 
Via Benzinga
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
NASDAQ:PTCT Shareholder Notice: Investigation over Possible Securities Laws Violations by PTC Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 10/10/2023 -- PTC Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 369 companies set new 52-week lows. 
Via Benzinga
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
 
Via Benzinga
Micron Technology To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday
Piper Sandler cut the price target for IBEX Limited (NASDAQ: IBEX) from $24 to $17. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. IBEX shares rose 0.3% to close at $13.59 on... 
Via Benzinga
US Stock Futures Edge Higher Amid Cautious Optimism; Analyst Says How Fed Packages Sept. Pause Key For Market Direction
US stock futures point to a higher opening on Monday after averages closed nearly flat in the week ended Sept. 15. 
Via Benzinga
Topics Economy
European Authority Gives Thumbs Down To PTC Therapeutics' Duchenne Therapy; Analyst Says It Can Overturn The Challenge
Friday morning, the Committee for Medicinal Products for Human Use of the European Medicines Agency gave a negative opinion on the conversion of the conditional marketing authorization to full... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. 
Via Benzinga
Nasdaq Down Over 1%; US Industrial Output Rises In August
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% points on Friday. The Dow traded down 0.52% to 34,727.05 while the NASDAQ fell 1.31% to 13,743.78. The... 
Via Benzinga
Topics Stocks
PTC Therapeutics, Planet Fitness, Kemper And Other Big Stocks Moving Lower On Friday
U.S. stocks traded higher, with the Dow Jones falling around 180 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Topics Stocks
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
Dow Dips 100 Points; US Export Prices Rise 1.3% In August
U.S. stocks traded lower this morning, with the Dow Jones falling around 100 points on Friday. Following the market opening Friday, the Dow traded down 0.31% to 34,799.50 while the NASDAQ fell 1.09% to... 
Via Benzinga
Topics Stocks
PTC Therapeutics Crashes 29% After European Regulators Reject Its Muscular Dystrophy Drug
The company is working on a treatment for Duchenne muscular dystrophy. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
Treating rare diseases is a tough but potentially lucrative business. With clinical trials coming due, here are three stocks to buy. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.